Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00315185 · ClinicalTrials.gov registry record · Phase 2

Study of Paclitaxel, Carboplatin, and Cetuximab for Advanced Lung Cancer

A Phase 2 study of Carcinoma, Non-Small Cell Lung, sponsored by Fox Chase Cancer Center.

Completed
Registry status
Phase 2
Development phase
53
Enrollment target
1
Study location

NCT00315185 is a Phase 2 study of Carcinoma, Non-Small Cell Lung that has completed, run by Fox Chase Cancer Center. The registered enrollment target is 53 participants, below the 323-participant average among 130 other Carcinoma, Non-Small Cell Lung trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00315185, a Phase 2 study of Carcinoma, Non-Small Cell Lung, has completed, sponsored by Fox Chase Cancer Center.

COMPLETED
Registry status
Phase 2
Development phase
53 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine the role of cetuximab (Erbitux) with chemotherapy for advanced colorectal carcinoma. This study will determine if this new agent can improve one's response to standard treatment.

Conditions Studied

Carcinoma, Non-Small Cell Lung

Interventions

  • DRUG Cetuximab

Study Locations (1)

Pennsylvania

  • Consultants in Medical Oncology & Hematology Inc. - Drexel Hill

Trial Details

FieldValue
Enrollment Target 53 participants
Start Date 2004-12
Est. Completion 2008-06
Phase Phase 2

Sponsor

Fox Chase Cancer Center

183 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00315185

The ClinicalTrials.gov registry entry for NCT00315185 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 53 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 323-participant average among 130 other Carcinoma, Non-Small Cell Lung trials with a reported enrollment target (84% lower). The listed sponsor is Fox Chase Cancer Center, which has 183 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Carcinoma, Non-Small Cell Lung appearing as the primary indexed condition, and to 1 intervention - of which Cetuximab is the first listed.

NCT00315185 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT00315185 about?

NCT00315185 is a clinical study titled "Study of Paclitaxel, Carboplatin, and Cetuximab for Advanced Lung Cancer". The purpose of this study is to determine the role of cetuximab (Erbitux) with chemotherapy for advanced colorectal carcinoma. This study will determine if this new agent can improve one's response to standard treatment.

What is the current status of trial NCT00315185?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 53 participants. The study started on 2004-12. Estimated completion is 2008-06.

What conditions does trial NCT00315185 study?

This clinical trial studies the following conditions: Carcinoma, Non-Small Cell Lung.

What interventions are being tested in trial NCT00315185?

The interventions under investigation include: Cetuximab (DRUG).

Who is sponsoring clinical trial NCT00315185?

This trial is sponsored by Fox Chase Cancer Center, which has 183 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00315185 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Carcinoma, Non-Small Cell Lung

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Carcinoma, Non-Small Cell Lung

All registered trials for this condition

Pennsylvania

All trials with a study site in Pennsylvania

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.